Stockreport

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

GeoVax Labs, Inc.  (GOVX) 
NASDAQ:AMEX Investor Relations: geovax.com/contact-geovax.html
PDF Adds to Growing Portfolio of Intellectual Property Assets ATLANTA, Ga., Dec. 09, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company de [Read more]